Seizures in infancy in the offspring of women with epilepsy

Frank J E Vajda1,2, Terence J O'Brien1,2, Janet E Graham1

  • 1Department of Medicine and Neurosciences, Royal Melbourne Hospital and University of Melbourne, Parkville, Vic., Australia.

Insights

Infants born to mothers with epilepsy have a 2.40% incidence of seizures in their first year of life. Maternal epilepsy type and seizure control during pregnancy are key factors influencing infant seizure risk.

Area of Science:

  • Neurology
  • Pediatrics
  • Obstetrics

Background:

  • Epilepsy affects numerous pregnancies globally.
  • Understanding risks for offspring is crucial for prenatal counseling.
  • Limited data exists on seizure incidence in infants of epileptic mothers.

Purpose of the Study:

  • To determine the incidence of seizures in infants during their first year of life.
  • To identify factors associated with increased seizure risk in these infants.

Main Methods:

  • Analysis of data from the Australian Register of Antiepileptic Drugs in Pregnancy.
  • Longitudinal follow-up of infants for one year post-birth.

Main Results:

  • Overall seizure incidence was 2.40% in infants of mothers with epilepsy.
  • Febrile seizures occurred in 0.92% of infants, higher than the general population.
  • Infants of mothers with generalized epilepsy and those with uncontrolled seizures during pregnancy had higher risks.
  • Fetal malformations were also associated with increased seizure likelihood.

Conclusions:

  • Findings provide valuable information for counseling mothers with epilepsy.
  • Achieving maternal seizure control throughout pregnancy is recommended.
  • Monitoring infants for seizures, especially those with risk factors, is important.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
638
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
708
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K